Nuzenio

Attovia Therapeutics

Attovia Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 5 publisher sources 100/100 entity strength

Latest news

symbol__ Stock Quote Price and Forecast - CNNCNN · Sun, 09 Aug 2026 16:52:47 GMTATTO SEC Filings - Attovia Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock TitanStock Titan · Sun, 09 Aug 2026 09:30:27 GMTAttovia Therapeutics (ATTO) director Angie You receives 27,000 stock options at $17 - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:44 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Business Officer - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Medical Officer - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards CSO Petter Veiby 140,000 options at $17 - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) insider Redmile converts 782,854 preferred shares and buys 600,000 in IPO - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:16 GMTAttovia Therapeutics (ATTO) Institutional Ownership 2026 $ATTO - MarketBeatMarketBeat · Fri, 07 Aug 2026 19:17:04 GMT

Timeline

Sun, 09 Aug 2026 16:52:47 GMTsymbol__ Stock Quote Price and Forecast - CNN
Sun, 09 Aug 2026 09:30:27 GMTATTO SEC Filings - Attovia Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sat, 08 Aug 2026 18:11:44 GMTAttovia Therapeutics (ATTO) director Angie You receives 27,000 stock options at $17 - Stock Titan
Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Business Officer - Stock Titan
Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Medical Officer - Stock Titan
Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards CSO Petter Veiby 140,000 options at $17 - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Attovia Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.